학술논문

p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR)
Document Type
article
Source
Cell. 184(3)
Subject
Biochemistry and Cell Biology
Biological Sciences
Stem Cell Research
Brain Disorders
ALS
Genetics
Frontotemporal Dementia (FTD)
Neurodegenerative
Acquired Cognitive Impairment
Rare Diseases
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Stem Cell Research - Induced Pluripotent Stem Cell - Human
Dementia
Stem Cell Research - Induced Pluripotent Stem Cell
Neurosciences
1.1 Normal biological development and functioning
Underpinning research
Aetiology
2.1 Biological and endogenous factors
Neurological
Animals
Apoptosis Regulatory Proteins
Axons
C9orf72 Protein
Cell Death
Cells
Cultured
Cerebral Cortex
Chromatin
DNA Damage
DNA Repeat Expansion
Disease Models
Animal
Drosophila
Mice
Inbred C57BL
Nerve Degeneration
Protein Stability
Transcription
Genetic
Tumor Suppressor Protein p53
Tumor Suppressor Proteins
Mice
ATAC-seq
C9orf72
TDP-43
amyotrophic lateral sclerosis
axonal degeneration
neurodegeneration
p53
puma
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
The most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) is a GGGGCC repeat expansion in the C9orf72 gene. We developed a platform to interrogate the chromatin accessibility landscape and transcriptional program within neurons during degeneration. We provide evidence that neurons expressing the dipeptide repeat protein poly(proline-arginine), translated from the C9orf72 repeat expansion, activate a highly specific transcriptional program, exemplified by a single transcription factor, p53. Ablating p53 in mice completely rescued neurons from degeneration and markedly increased survival in a C9orf72 mouse model. p53 reduction also rescued axonal degeneration caused by poly(glycine-arginine), increased survival of C9orf72 ALS/FTD-patient-induced pluripotent stem cell (iPSC)-derived motor neurons, and mitigated neurodegeneration in a C9orf72 fly model. We show that p53 activates a downstream transcriptional program, including Puma, which drives neurodegeneration. These data demonstrate a neurodegenerative mechanism dynamically regulated through transcription-factor-binding events and provide a framework to apply chromatin accessibility and transcription program profiles to neurodegeneration.